Cargando…
Using autoantibody signatures to define cancer risk in dermatomyositis
Dermatomyositis is an idiopathic inflammatory myopathy with a highly heterogeneous disease course. Although there is a known increase in cancer risk surrounding the time of dermatomyositis diagnosis, the mechanisms driving this increased risk are not well understood. Further, there are no current st...
Autores principales: | Turnier, Jessica L., Kahlenberg, J. Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759773/ https://www.ncbi.nlm.nih.gov/pubmed/35040442 http://dx.doi.org/10.1172/JCI156025 |
Ejemplares similares
-
The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021) -
Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
por: Marzęcka, Milena, et al.
Publicado: (2022) -
Clinical and autoantibody phenotypes of juvenile dermatomyositis
por: Boyarchuk, Oksana, et al.
Publicado: (2022) -
The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum
por: Marasandra Ramesh, Harshita, et al.
Publicado: (2022) -
Imaging Mass Cytometry Reveals Predominant Innate Immune Signature and Endothelial–Immune Cell Interaction in Juvenile Myositis Compared to Lupus Skin
por: Turnier, Jessica L., et al.
Publicado: (2022)